Your browser doesn't support javascript.
loading
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.
Yau, Thomas; Tai, David; Chan, Stephen Lam; Huang, Yi-Hsiang; Choo, Su Pin; Hsu, Chiun; Cheung, Tan To; Lin, Shi-Ming; Yong, Wei Peng; Lee, Joycelyn; Leung, Thomas; Shum, Tracy; Yeung, Cynthia S Y; Tai, Anna Yin-Ping; Law, Ada Lai Yau; Cheng, Ann-Lii; Chen, Li-Tzong.
Afiliación
  • Yau T; Department of Medicine, The University of Hong Kong, Hong Kong, China.
  • Tai D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Chan SL; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China.
  • Huang YH; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Choo SP; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Hsu C; Curie Oncology, Singapore, Singapore.
  • Cheung TT; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Lin SM; Department of Surgery, The University of Hong Kong, Hong Kong, China.
  • Yong WP; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkuo, Taiwan.
  • Lee J; Department of Haematology-Oncology, National University of Singapore, Singapore, Singapore.
  • Leung T; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Shum T; Department of Medical Oncology, Hong Kong Sanatorium & Hospital, Hong Kong, China.
  • Yeung CSY; Department of Oncology, Princess Margaret Hospital, Hong Kong, China.
  • Tai AY; Union Hospital, Hong Kong, China.
  • Law ALY; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
  • Cheng AL; Chiron Medical, Hong Kong, China.
  • Chen LT; Department of Internal Medicine and Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Liver Cancer ; 11(5): 426-439, 2022 Sep.
Article en En | MEDLINE | ID: mdl-36158587

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Liver Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Liver Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza